DEF 14C

DEFINITIVE INFORMATION STATEMENT

Company: Inhibitor Therapeutics, Inc.
Filed: April 25, 2016
Period of Report: April 25, 2016
Accession Number: 0001193125-16-554362

View Document ↗ View on SEC.gov ↗